Turkey’s first coronavirus vaccine, developed in China, was administered to a health worker on Sept. 28 in Istanbul University’s Cerrahpaşa Medical Faculty.
Asım Baştürk, 53 years old, volunteered for the phase 3 test of the vaccine, kicking off the latest stage of its development.
“I volunteered for this of my own will. Of course, we want this [virus] which is creating trouble for Turkey and the world to be eliminated soon,” he said.
Giving a break up of patients they attended to since March, faculty dean Dr. Mustafa Sait Gönen said that out of 335,000 patients who visited the facility; 27,000 were treated for COVID-19 and 77,000 tests were conducted.
“This is an important day for the Cerrahpaşa Medical Faculty. This struggle [against the virus] continues in Cerrahpaşa, as in other hospitals and in the world,” he added.